Elena Ridloff, EVP and CFO at ACADIA PHARMACEUTICALS INC (ACAD), sold 60,980 shares at $50.59 ($3.0M) on 2019-12-09, disclosed to the SEC on 2019-12-11.
Open-market sale of $3.0M ACAD by EVP and CFO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $49.09 | 19,478 | $956K | 31.7% |
| 2 | $49.09 | 19,478 | $956K | 31.7% |
| 3 | $49.81 | 5,502 | $274K | 9.1% |
| 4 | $49.81 | 5,502 | $274K | 9.1% |
| 5 | $50.59 | 11,020 | $558K | 18.5% |
| Total | $49.49 avg | 60,980 |
| $3.0M |
| 100% |
| Filing → |
| SION | SELL | 2025-09-03 | $462K | — | Filing → |
| SION | SELL | 2025-08-28 | $1.1M | — | Filing → |
| SION | SELL | 2025-08-21 | $1.9M | — | Filing → |